世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

リポソーム薬物送達デバイス市場レポート:2022-2032


Liposomal Drug Delivery Devices Market Report 2022-2032

レポート詳細 リポソーム薬物送達デバイスの市場レポート 2022-2032 :本レポートは、新たな収益の柱を目指すリーディングカンパニーが、業界とその背景にあるダイナミクスをより深く理解する上で、非... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 図表数 言語
Visiongain
ヴィジョンゲイン社
2022年6月21日 GBP4,500
部署ライセンス
ライセンス・価格情報・注文方法はこちら
535 660 英語

※上記価格は部署ライセンス(Departmental licence)価格です。
その他の価格についてはデータリソースまでお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

レポート詳細

リポソーム薬物送達デバイスの市場レポート 2022-2032:本レポートは、新たな収益の柱を目指すリーディングカンパニーが、業界とその背景にあるダイナミクスをより深く理解する上で、非常に有益なものとなるでしょう。また、異業種への進出や新地域での既存事業の拡大を目指す企業にとっても有用なレポートです。

リポソームは、治療薬の送達を向上させるための薬物キャリアとして広く研究されている
リポソームは、体内の標的部位への薬物送達を改善するための薬物キャリアとして広く研究されている。その結果、多くのブレークスルーが達成され、この技術が特定の疾患の治療に役立つ可能性があります。リポソームは、薬の吸収を高める一方で、速やかな崩壊や副作用を回避または最小化し、生物学的半減期を長くし、毒性を低下させる。リポソームは生体適合性、生分解性、不活性、非免疫原性の脂質であるため、薬物送達キャリアーとしてユニークな存在となっています。

リポソーム製剤は、免疫原性が低く、毒性が低く、より大きな荷物を標的部位に運ぶことができるため、過去10年間で科学的関心が著しく高まっており、ウイルスベクターよりも安全であることが実証されています。リポソームを用いた薬物送達法は、抗がん剤、抗真菌剤、抗炎症剤の投与や、治療用遺伝子療法に用いられている。

標的ドラッグデリバリーへの意識の高まりが市場成長を後押し
標的薬物送達に対する意識の高まり、癌発生の増加、リポソームの機能性の向上が、予測年におけるリポソーム医薬品の市場成長を促進すると考えられます。一方、リポソーム薬物送達デバイスの価格の上昇は、予測期間中のリポソーム薬物送達デバイス産業の拡大を妨げると予測されます。

さらに、低毒性と優れた有効性により、臨床でのリポソームの採用が拡大していることは、リポソーム医薬品市場の将来的な発展にさらなる展望を与えるでしょう。一方、リポソームの半減期が早いことが、近い将来、リポソーム医薬品市場の妨げになる可能性があります。

北米のリポソーム薬物送達デバイス市場は、2022年に世界のリポソーム薬物送達市場をリードすると予想され、予測期間中も、米国の需要増加により、その傾向が続くと予測されます。卵巣がん、AIDS関連カポジ肉腫、真菌感染症などの患者の治療が、地域市場の拡大を牽引する主要な治療法となっています。さらに、アジア太平洋地域のリポソーム薬物送達デバイスは、2022年から2032年にかけて11.5%の最高のCAGRで成長すると予想されます。アジア太平洋地域のリポソーム薬物送達デバイス市場の需要は、中国、インド、日本によって促進されると予想されます。スティバネート耐性への懸念が高まる中、インドは世界の内臓リーシュマニア症(VL)感染の約半分を占めており、予測期間中に地域の成長を高めるとみられます。

マーケットリサーチレポートを購入する前に、どのような質問をすべきでしょうか?
- リポソーム薬物送達デバイスの市場はどのように進化しているのか?
- リポソーム薬物送達デバイス市場の推進要因と抑制要因は何か?
- リポソーム薬物送達デバイスの各サブマーケットセグメントは予測期間中にどのように成長し、2032年にこれらのサブマーケットが占める収益はどの程度になるのでしょうか?
- 2022年から2032年にかけて、各リポソーム薬物送達デバイスのサブマーケットの市場シェアはどのように推移するのでしょうか?
- 2022年から2032年にかけて、市場全体の主なドライバーは何でしょうか?
- リポソーム薬物送達デバイスの主要市場はマクロ経済のダイナミクスに概ね追随するのか、それとも個々の国内市場が他を凌駕するのか?
- 2032年までに各国市場のシェアはどのように変化し、どの地域が2032年に市場をリードするのでしょうか?
- 主要プレイヤーは誰か、また予測期間中の展望は?
- これらの主要企業のリポソーム薬物送達デバイスのプロジェクトはどのようなものですか?
- 2022年から2032年の間に、業界はどのように進化していくのか?現在および今後10年間に実施されるリポソーム薬物送達デバイスのプロジェクトはどのような意味を持つのか?
- リポソーム薬物送達デバイス市場をさらに拡大するために、製品の商業化の必要性は高いか?
- リポソーム薬物送達デバイス市場はどこへ向かい、どのようにして市場の最前線に立つことができるのか?
- 新製品やサービスラインに対する最適な投資オプションは何か?
- 企業を新たな成長軌道に乗せ、C-suiteに移行させるための重要な展望とは?

このことがリポソーム薬物送達デバイス市場に現在、そして今後10年間、どのような影響を与えるかを知る必要があります。
- 535ページにわたる本レポートでは、337の表と323のグラフを独占的に提供します。
- このレポートでは、業界における主要な収益性の高い分野をハイライトしているため、今すぐその分野をターゲットにすることができます。
- 世界、地域、国別の売上高と成長率を詳細に分析しています。
- 競合他社が成功した主なトレンド、変化、収益予測をハイライトしています。

本レポートは、リポソーム薬物送達デバイス市場が今後10年間にどのように発展し、COVID-19の景気後退と回復の変動に沿うものであるかを今日あなたにお伝えします。この市場は、過去10年間のどの時点よりも今が重要であると考えています。

レポートでは、COVID-19のバリエーションや経済データなど、お客様の市場に特化した独自の情報をお届けしています。

2032年までの予測やその他の分析により、商業的な展望が見えてくる
- 2032年までの収益予測に加え、直近の実績、成長率、市場シェアもご覧いただけます。
- ビジネスの展望や展開など、独自の分析もご覧いただけます。
- 定性的分析(市場力学、促進要因、機会、阻害要因、課題など)、コスト構造、リポソーム薬物送達デバイスの価格上昇の影響、最近の開発状況などをご覧いただけます。

本レポートでは、COVID-19が業界と貴社にどのような影響を与えるかについて、データ分析と貴重な洞察を掲載しています。本レポートでは、COVID-19の4つの回収パターンとその影響、すなわち「V」、「L」、「W」、「U」について論じています。

報告書の対象セグメント

タイプ
- リポソームドキソルビシン
- リポソームパクリタキセル
- リポソームアムホテリシンB

技術
- ステルスリポソーム技術
- 非PEG化リポソーム技術
- デポフォームリポソーム技術

用途
- 真菌症
- がん治療
- 疼痛治療
- ウイルスワクチン
- 光線力学的療法

エンドユーザー
- 病院
- 診断センター
- 外来手術センター/クリニック

世界市場全体およびセグメントの収益予測に加え、4地域および20の主要国市場の収益予測も掲載しています。

北アメリカ
- 米国
- カナダ

欧州
- ドイツ
- 英国
- フランス
- イタリア
- スペイン
- ロシア
- その他の欧州

アジア太平洋
- 日本
- 中国
- インド
- オーストラリア
- 韓国
- その他のアジア太平洋地域

ラテンアメリカ
- ブラジル
- メキシコ
- その他のラテンアメリカ地域

中東・アフリカ
- GCC
- 南アフリカ
- その他の中東・アフリカ地域

リポソーム薬物送達デバイス市場の2022年から2032年までの主要企業のプロファイルと、これらの企業の事業のこのセグメントに焦点を当てたものも含まれています。

主要企業と市場成長の可能性
・ AbbVie Inc. (AbbVie)
・ Bavarian Nordic A/S
・ Catalent, Inc.
・ Charles River Laboratories International, Inc.
・ Emergent BioSolutions Inc.
・ Eurofins Scientific SE
・ FUJIFILM Holdings Corporation
・ GlaxoSmithKline PLC
・ Kemwell Biopharma
・ Lonza Group AG (Lonza)
・ Merck KGaA
・ Pfizer Inc. (Pfizer)
・ Richter-Helm BioLogics
・ Samsung Biologics Co Ltd
・ Sanofi SA
・ Serum Institute of India
・ Siegfried Holding AG
・ Thermo Fisher Scientific Inc.
・ Wacker Biotech B.V.
・ WuXi Biologics Cayman Inc

リポソーム薬物送達デバイス市場の世界全体収益、金額ベースで2022年から2032年まで、市場は2022年に40億9110万米ドルを超えると、我々の仕事は計算しています。また、2032年までの間に収益が大きく伸びると予測しています。本調査では、最も大きな可能性を秘めた企業を特定します。彼らの能力、進歩、商業的展望を知ることで、一歩先を行くことができます。

リポソーム薬物送達デバイスの市場、2022年から2032年までのレポートはどのように役立つのでしょうか?
530ページを超えるレポートでは、要約すると以下のような知識を得ることができます。

- リポソーム薬物送達デバイス市場の2032年までの収益予測、タイプ、技術、用途、エンドユーザー別に世界と地域レベルでそれぞれ予測 - 業界の展望を見出し、投資と収益に最も有利な場所を発見する。

- 4地域と20の主要国市場の2032年までの収益予測 - リポソーム薬物送達デバイス市場、北米、欧州、アジア太平洋、LAMEAの2022年から2032年までの市場予測をご覧いただけます。また、米国、カナダ、メキシコ、ブラジル、ドイツ、フランス、英国、イタリア、中国、インド、日本、オーストラリアなどの主要経済圏の市場も予測されています。

- 既存企業および市場参入を目指す企業の展望 - リポソーム薬物送達デバイス市場に関与する主要企業20社の企業プロファイルを含む、2022年から2032年までの市場。

定量的・定性的な分析と独自の予測をご覧いただけます。私たちのレポートだけが持つ情報を入手し、貴重なビジネスインテリジェンスを得ることができます。

他にはない情報
私たちの新しいレポートがあれば、知識の遅れを取り戻し、チャンスを逃す可能性が低くなります。私たちの研究が貴社の調査、分析、意思決定にどのように役立つかをご覧ください。Visiongainの研究は、リポソーム薬物送達デバイス市場、2022年から2032年、市場をリードする企業のための商業分析を必要とするすべての人のためのものです。データ、トレンド、予測を見つけることができます。



ページTOPに戻る


目次

目次

1.レポートの概要
1.1 リポソーム薬物送達デバイス市場の紹介
1.2 リポソーム薬物送達デバイス市場の定義
1.3 本レポートを読むべき理由
1.4 本レポートが提供するもの
1.5 本分析報告書が回答する主な質問には以下が含まれる。
1.6 本レポートは誰のためのものか?
1.7 方法論
1.7.1 COVID-19の影響。回復シナリオ
1.7.2 市場評価・予測手法
1.8 よくある質問と回答(FAQ)
1.9 関連するVisiongainレポート
1.10 Visiongainについて

2 エグゼクティブサマリー

3 マーケットダイナミクス
3.1 ドライバ
3.1.1 リポソーム製剤によるナノメディシン送達の実現
3.1.2 リポソーム薬物送達の癌治療への応用の拡大が市場成長を促進する
3.1.3 ナノメディクスの採用による市場成長の促進
3.1.4 市場成長を促進する製品認可の増加
3.1.5 リポソームベースの製剤における技術的進歩が市場需要に拍車をかける
3.2 制約事項
3.2.1 標準的な規制の欠如は市場成長を阻害する
3.2.2 リポソーム薬物送達デバイスの高コスト
3.2.3 滅菌とカプセル化の有効性の問題が市場成長を抑制する
3.3 オポチュニティ
3.3.1 COVID-19の出現は有利な成長機会を提供すると予想される
3.3.2 ナノメディシンは市場プレイヤーに有利な成長の見通しを提供すると予想される
3.4 SWOT分析
3.4.1 市場の強み
3.4.2 市場の弱点
3.4.3 市場の好機
3.4.4 市場の脅威
3.5 ポーターのファイブフォース分析
3.5.1 競合他社の競争力(高)
3.5.2 サプライヤーパワー(低〜中)
3.5.3 バイヤーパワー(中)
3.5.4 代替品からの脅威(低)
3.5.5 新規参入者の脅威(低~中)
3.6 PEST分析
3.6.1 リポソーム薬物送達デバイスの市場に影響を与える政治的要因
3.6.2 リポソーム薬物送達デバイスの市場に影響を与える経済的要因
3.6.3 リポソーム薬物送達デバイスの市場に影響を与える社会的要因
3.6.4 リポソーム薬物送達デバイスの市場に影響を与える技術的要因

4 リポソーム薬物送達デバイス市場:タイプ別
4.1 リポソームドキソルビシンセグメント市場予測、2022年~2032年
4.1.1 COVID-19の影響回復シナリオ(V、U、W、L)
4.2 リポソームパクリタキセルセグメント市場予測、2022年~2032年
4.2.1 COVID-19の影響回復シナリオ(V, U, W, L)
4.3 リポソーマル・アムホテリシンBセグメント市場予測、2022年〜2032年
4.3.1 COVID-19の影響回復シナリオ(V, U, W, L)

5 リポソーム薬物送達デバイス市場:技術別
5.1 ステルスリポソーム技術セグメント市場予測、2022年~2032年
5.1.1 COVID-19の影響回復シナリオ(V、U、W、L)
5.2 非PEG化リポソーム技術セグメント市場予測、2022年~2032年
5.2.1 COVID-19インパクトリカバリーシナリオ(V、U、W、L)
5.3 デポフォームリポソーム技術セグメント市場予測、2022年~2032年
5.3.1 COVID-19インパクトリカバリーシナリオ(V, U, W, L)

6 リポソーム薬物送達デバイ市場:用途別
6.1 真菌症セグメント市場予測、2022年~2032年
6.1.1 COVID-19の影響回復シナリオ(V、U、W、L)
6.2 がん治療セグメントの市場予測、2022年〜2032年
6.2.1 COVID-19影響回復シナリオ(V, U, W, L)
6.3 ペインマネジメントセグメント市場予測、2022年~2032年
6.3.1 COVID-19インパクト回復シナリオ(V, U, W, L)
6.4 ウイルスワクチンセグメント市場予測、2022年〜2032年
6.4.1 COVID-19インパクト回復シナリオ(V, U, W, L)
6.5 光線力学療法セグメントの市場予測、2022年〜2032年
6.5.1 COVID-19影響度回復シナリオ(V、U、W、L)

7 リポソーム薬物送達デバイス市場:エンドユーザー別
7.1 病院セグメントの市場予測、2022~2032年
7.1.1 COVID-19の影響回復シナリオ(V、U、W、L)
7.2 診断センター(ラジオ・イメージング)セグメント市場予測、2022年~2032年
7.2.1 COVID-19影響回復シナリオ(V,U,W,L)
7.3 外来手術センター/クリニック セグメント市場予測、2022年〜2032年
7.3.1 COVID-19影響回復シナリオ(V,U,W,L)

8 地域および主要国のリポソーム薬物送達デバイス市場予測 2022~2032年
8.1 紹介
8.2 リポソーム薬物送達デバイスの世界市場:地域別予測 2022-2032
8.3 COVID-19の影響回復シナリオ(V、U、W、L)

9 北米のリポソーム薬物送達デバイス市場
9.1 紹介
9.2 北米リポソーム薬物送達デバイスの国別市場予測(2022~2032年)
9.3 北米リポソーム薬物送達デバイスのタイプ別市場予測
9.4 北米リポソーム薬物送達デバイスの技術別市場予測
9.5 北米リポソーム薬物送達デバイスの市場規模予測(用途別)
9.6 北米リポソーム薬物送達デバイスのエンドユーザー別市場展望
9.7 米国リポソーム薬物送達デバイスの市場予測(2022年~2032年)
9.7.1 遺伝子疾患の負担増がリポソーム薬物送達デバイスの市場成長を促進する
9.7.2 癌の負担増が地域の成長を促進する
9.7.3 米国は市場プレイヤーの大規模な投資を目撃している
9.7.4 Pacira社、小児患者を対象としたExparel® (Bupivacaine Liposome Injectable Suspension)の新薬承認申請補足をFDAより発表
9.7.5 COVID-19の影響回復シナリオ(V, U, W, L)。米国リポソーム薬物送達デバイスの市場予測、2022-2032年
9.8 カナダのリポソーム薬物送達デバイスの市場予測、2022年〜2032年
9.8.1 地域全体で高齢化が進み、市場成長を促進
9.8.2 癌患者の増加によりカナダ市場プレイヤーは有利な成長展望を提供する
9.8.3 COVID-19の影響回復シナリオ(V、U、W、L)。カナダのリポソーム薬物送達デバイスの市場予測、2022-2032年

10 欧州のリポソーム薬物送達デバイス市場
10.1 紹介
10.2 欧州のリポソーム薬物送達デバイスの国別市場予測(2022年~2032年)
10.3 欧州のリポソーム薬物送達デバイスのタイプ別市場予測
10.4 欧州のリポソーム薬物送達デバイスの市場予測(技術別)
10.5 欧州のリポソーム薬物送達デバイスの市場規模予測(用途別)
10.6 欧州のリポソーム薬物送達デバイスのエンドユーザー別市場展望
10.7 ドイツのリポソーム薬物送達デバイスの市場予測、2022-2032年
10.7.1 ドイツは高品質な研究用製品の開発・製造に理想的な立地条件
10.7.2 リポソームベースの治療に対する需要の高まりが市場成長を促進する
10.7.3 エボニックは、リポソーム医薬品の迅速かつ効果的な製造のための次世代押出機LIPEX®を発売した
10.7.4 COVID-19の影響回復シナリオ(V、U、W、L)。ドイツのリポソーム薬物送達デバイスの市場予測、2022年~2032年
10.8 イギリス リポソーム薬物送達デバイスの市場予測、2022年〜2032年
10.8.1 T&T Scientific社が低価格のフルアセンブルリポソーム抽出装置を発表
10.8.2 Croda International PLCによるAvanti Polar Lipids, Inc.の買収
10.8.3 がん患者の増加による市場成長の促進
10.8.4 侵襲性真菌症が地域市場の成長を促進する
10.8.5 COVID-19の影響回復シナリオ(V、U、W、L)。イギリスのリポソーム薬物送達デバイスの市場予測、2022年~2032年
10.9 フランスのリポソーム薬物送達デバイスの市場予測、2022年~2032年
10.9.1 フランスのバイオテクノロジー分野の強化ニーズの高まりが地域のリポソーム薬物送達デバイス市場の成長を促進
10.9.2 慢性疾患の発生率の上昇が地域の成長を促進する
10.9.3 COVID-19の影響回復シナリオ(V、U、W、L)。フランスのリポソーム薬物送達デバイスの市場予測、2022-2032年
10.10 イタリアのリポソーム薬物送達デバイスの市場予測、2022年〜2032年
10.10.1 イタリアは欧州全域の主要な製薬メーカー
10.10.2 成長する研究活動が地域の成長を促進する
10.10.3 COVID-19の影響回復シナリオ(V、U、W、L)。イタリアのリポソーム薬物送達デバイスの市場予測、2022-2032年
10.11 スペインのリポソーム薬物送達デバイスの市場予測、2022年〜2032年
10.11.1 癌の負担増が市場成長を促進する
10.11.2 GPファーマの注射用リポソーム
10.11.3 COVID-19の影響回復シナリオ(V、U、W、L)。11 スペインのリポソーム薬物送達デバイスの市場予測(2022-2032年
10.12 ロシアのリポソーム薬物送達デバイスの市場予測、2022年~2032年
10.12.1 政府の取り組みがロシアのリポソーム薬物送達デバイスの市場プレイヤーに有利な成長見通しを提供
10.12.2 COVID-19の影響回復シナリオ(V、U、W、L)。ロシアのリポソーム薬物送達デバイス市場予測、2022-2032年
10.13 欧州以外のリポソーム薬物送達デバイス市場予測、2022年~2032年
10.13.1 COVID-19の影響回復シナリオ(V、U、W、L)。その他の欧州のリポソーム薬物送達デバイスの市場予測、2022-2032年

11 アジア太平洋地域のリポソーム薬物送達デバイスの市場
11.1 紹介
11.2 アジア太平洋地域のリポソーム薬物送達デバイスの国別市場予測(2022~2032年)
11.3 アジア太平洋地域のリポソーム薬物送達デバイスのタイプ別市場予測
11.4 アジア太平洋地域のリポソーム薬物送達デバイスの技術別市場予測
11.5 アジア太平洋地域のリポソーム薬物送達デバイスの市場規模予測(用途別)
11.6 アジア太平洋地域のリポソーム薬物送達デバイスのエンドユーザー別市場展望
11.7 日本のリポソーム薬物送達デバイスの市場予測、2022-2032年
11.7.1 日本の製薬業界は大きく変化している
11.7.2 富士フイルム、リポソーム製剤のプロセス開発・製造受託サービスを開始
11.7.3 COVID-19の影響回復シナリオ(V,U,W,L)。日本リポソーム薬物送達デバイスの市場予測、2022年〜2032年
11.8 中国 リポソーム薬物送達デバイスの市場予測、2022年〜2032年
11.8.1 中国政府による医療改革は有利な成長機会を提供する
11.8.2 陸羽製薬グループ、デュラグルチド注射液(BA5101)の承認取得を発表
11.8.3 TLCバイオサイエンシズ、TLC599の第2相試験の結果を発表
11.8.4 COVID-19の影響回復シナリオ(V, U, W, L)。中国のリポソーム薬物送達デバイスの市場予測、2022-2032年
11.9 インドのリポソーム薬物送達デバイスの市場予測、2022年〜2032年
11.9.1 インド全土の製薬企業が能力を高めている
11.9.2 アムホテリシンBリポソーム注のDGCI(インド医薬品監督庁)による承認取得
11.9.3 高齢化が市場の成長を促進する
11.9.4 COVID-19の影響回復シナリオ(V、U、W、L)。インド リポソーム薬物送達デバイスの市場予測、2022-2032年
11.10 オーストラリア リポソーム薬物送達デバイスの市場予測、2022年~2032年
11.10.1 UNSWチームは、より安全なCRISPRデリバリーのために光活性化リポソームを利用する
11.10.2 COVID-19の影響回復シナリオ(V、U、W、L)。オーストラリア リポソーム薬物送達デバイスの市場予測、2022-2032年
11.11 韓国のリポソーム薬物送達デバイスの市場予測、2022年〜2032年
11.11.1 韓国の研究者はリポソームの大量生産技術の商業化の準備が整った
11.11.2 COVID-19の影響回復シナリオ(V、U、W、L)。韓国のリポソーム薬物送達デバイスの市場予測、2022年~2032年
11.12 アジア太平洋地域のその他のリポソーム薬物送達デバイスの市場予測、2022年~2032年
11.12.1 COVID-19影響回復シナリオ(V、U、W、L)。その他のアジア太平洋地域のリポソーム薬物送達デバイスの市場予測、2022-2032年

12 中南米のリポソーム薬物送達デバイス市場
12.1 紹介
12.2 中南米リポソーム薬物送達デバイスの国別市場予測(2022~2032年)
12.3 中南米リポソーム薬物送達デバイスのタイプ別市場展望
12.4 中南米リポソーム薬物送達デバイスの技術別市場展望
12.5 中南米リポソーム薬物送達デバイスの市場展望(用途別
12.6 中南米リポソーム薬物送達デバイスのエンドユーザー別市場展望
12.7 ブラジル リポソーム薬物送達デバイスの市場予測(2022~2032年
12.7.1 現在、ブラジルは中南米のリポソーム薬物送達デバイス市場を支配している
12.7.2 COVID-19の影響回復シナリオ(V、U、W、L)。7.2 COVID-19影響回復シナリオ(V、U、W、L):ブラジルのリポソーム薬物送達デバイス市場予測、2022-2032年
12.8 メキシコのリポソーム薬物送達デバイスの市場予測、2022年~2032年
12.8.1 市場プレイヤーに有利な成長機会を提供する医療制度改革の実施
12.8.2 COVID-19の影響回復シナリオ(V、U、W、L)。メキシコのリポソーム薬物送達デバイスの市場予測、2022年~2032年
12.9 中南米のその他のリポソーム薬物送達デバイス市場予測、2022年~2032年
12.9.1 COVID-19影響回復シナリオ(V、U、W、L)。中南米の残りのリポソーム薬物送達デバイスの市場予測、2022-2032年

13 中東・アフリカのリポソーム薬物送達デバイス市場
13.1 はじめに
13.2 中東・アフリカのリポソーム薬物送達デバイスの国別市場予測(2022年~2032年)
13.3 中東・アフリカのリポソーム薬物送達デバイスのタイプ別市場展望
13.4 中東・アフリカのリポソーム薬物送達デバイスの技術別市場予測
13.5 中東・アフリカのリポソーム薬物送達デバイスの用途別市場展望
13.6 中東・アフリカのリポソーム薬物送達デバイスのエンドユーザー別市場展望
13.7 GCCリポソーム薬物送達デバイスの市場展望(2022~2032年)
13.7.1 医療投資の拡大が2032年まで地域の成長を促進する
13.7.2 COVID-19の影響回復シナリオ(V、U、W、L)。GCCリポソーム薬物送達デバイスの市場予測、2022年~2032年
13.8 南アフリカのリポソーム薬物送達デバイスの市場予測、2022年~2032年
13.8.1 感染症負担の増大が今後10年間の市場成長を促進
13.8.2 COVID-19の影響回復シナリオ(V、U、W、L)。南アフリカ リポソーム薬物送達デバイスの市場予測、2022年~2032年
13.9 その他の中東・アフリカ地域のリポソーム薬物送達デバイス市場予測、2022年~2032年
13.9.1 COVID-19インパクト回復シナリオ(V、U、W、L)。その他の中東・アフリカのリポソーム薬物送達デバイスの市場予測、2022-2032年

14 主要企業のプロフィール
14.1 企業ランキング(2021年)
14.2 最近の開発状況
14.3 武田薬品工業株式会社
14.3.1 会社概要
14.3.2 会社概要
14.3.3 財務分析
14.3.4 製品ベンチマーク
14.4 ノバルティスAG
14.4.1 企業スナップショット
14.4.2 会社概要
14.4.3 財務分析
14.4.4 ベンチマーキング
14.4.5 最新の開発状況
14.5 陸羽製薬グループ
14.5.1 会社概要
14.5.2 会社概要
14.5.3 ベンチマーキング
14.5.4 最新の開発状況
14.6 イプセンファーマ
14.6.1 企業スナップショット
14.6.2 会社概要
14.6.3 財務分析
14.6.4 製品ベンチマーク
14.6.5 最新の開発状況
14.7 セルシオン・インク
14.7.1 企業スナップショット
14.7.2 会社概要
14.7.3 ベンチマーキング製品
14.7.4 最新の開発状況
14.8 ギャレン・リミテッド
14.8.1 企業スナップショット
14.8.2 会社概要
14.8.3 ベンチマーキング
14.9 アステラス製薬
14.9.1 企業スナップショット
14.9.2 会社概要
14.9.3 財務分析
14.9.4 ベンチマーキング
14.9.5 最新の開発状況
14.10 アクロテックバイオファーマ
14.10.1 企業スナップショット
14.10.2 会社概要
14.10.3 ベンチマーキング
14.11 復旦張江
14.11.1 企業スナップショット
14.11.2 会社概要
14.11.3 ベンチマーキング
14.12 パシラ
14.12.1 企業スナップショット
14.12.2 会社概要
14.12.3 財務分析
14.12.4 ベンチマーキング
14.12.5 最新の開発状況
14.13 クリエイティブ・バイオラブズ
14.13.1 企業スナップショット
14.13.2 会社概要
14.13.3 ベンチマーキング
14.14 プレシジョン・ナノシステムズ社
14.14.1 企業スナップショット
14.14.2 会社概要
14.14.3 製品ベンチマーク
14.15 エンカプシュラ・ナノサイエンス・エルエルシー
14.15.1 企業スナップショット
14.15.2 会社概要
14.15.3 製品ベンチマーク
14.16 アバンティポーラリピッド社
14.16.1 企業スナップショット
14.16.2 会社概要
14.16.3 ベンチマーキング
14.17 ビアトリス社
14.17.1 企業スナップショット
14.17.2 会社概要
14.17.3 財務分析
14.17.4 ベンチマーキング
14.18 メリマク・ファーマシューティカルズ・インク
14.18.1 企業スナップショット
14.18.2 会社概要
14.18.3 製品ベンチマーク

15 結論と提言
15.1 結論
15.2 市場関係者への提言

表の一覧
Table 1 Global Liposomal Drug Delivery Devices Market Snapshot, 2022 & 2032 (US$ million, CAGR %)
Table 2 Candidate Liposomal Vaccine Formulations
Table 3 List of Clinically Approved Nanomedicines for Cancer Treatment
Table 4 Global Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR%)
Table 5 Liposome-based Drugs on Market
Table 6 Liposome-based Drugs in Clinical Trails
Table 7 Global Liposomal Drug Delivery Devices Market Forecast for Liposomal Doxorubicin Segment, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 8 Global Liposomal Drug Delivery Devices Market Forecast for Liposomal Doxorubicin Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 9 Global Liposomal Drug Delivery Devices Market Forecast for Liposomal Doxorubicin Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 10 Global Liposomal Drug Delivery Devices Market Forecast for Liposomal Doxorubicin Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 11 Global Liposomal Drug Delivery Devices Market Forecast for Liposomal Doxorubicin Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 12 Global Liposomal Drug Delivery Devices Market Forecast for Liposomal Paclitaxel Segment, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 13 Global Liposomal Drug Delivery Devices Market Forecast for Liposomal Paclitaxel Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 14 Global Liposomal Drug Delivery Devices Market Forecast for Liposomal Paclitaxel Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 15 Global Liposomal Drug Delivery Devices Market Forecast for Liposomal Paclitaxel Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 16 Global Liposomal Drug Delivery Devices Market Forecast for Liposomal Paclitaxel Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 17 Global Liposomal Drug Delivery Devices Market Forecast for Liposomal Amphotericin B Segment, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 18 Global Liposomal Drug Delivery Devices Market Forecast for Liposomal Amphotericin B Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 19 Global Liposomal Drug Delivery Devices Market Forecast for Liposomal Amphotericin B Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 20 Global Liposomal Drug Delivery Devices Market Forecast for Liposomal Amphotericin B Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 21 Global Liposomal Drug Delivery Devices Market Forecast for Liposomal Amphotericin B Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 22 Global Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ million, AGR%, CAGR%)
Table 23 Global Liposomal Drug Delivery Devices Market Forecast for Stealth Liposome Technology Segment, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 24 Global Liposomal Drug Delivery Devices Market Forecast for Stealth Liposome Technology Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 25 Global Liposomal Drug Delivery Devices Market Forecast for Stealth Liposome Technology Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 26 Global Liposomal Drug Delivery Devices Market Forecast for Stealth Liposome Technology Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 27 Global Liposomal Drug Delivery Devices Market Forecast for Stealth Liposome Technology Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 28 Global Liposomal Drug Delivery Devices Market Forecast for Non-PEGylated Liposome Technology Segment, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 29 Global Liposomal Drug Delivery Devices Market Forecast for Non-PEGylated Liposome Technology Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 30 Global Liposomal Drug Delivery Devices Market Forecast for Non-PEGylated Liposome Technology Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 31 Global Liposomal Drug Delivery Devices Market Forecast for Non-PEGylated Liposome Technology Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 32 Global Liposomal Drug Delivery Devices Market Forecast for Non-PEGylated Liposome Technology Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 33 Global Liposomal Drug Delivery Devices Market Forecast for DepoFoam Liposome Technology Segment, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 34 Global Liposomal Drug Delivery Devices Market Forecast for DepoFoam Liposome Technology Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 35 Global Liposomal Drug Delivery Devices Market Forecast for DepoFoam Liposome Technology Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 36 Global Liposomal Drug Delivery Devices Market Forecast for DepoFoam Liposome Technology Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 37 Global Liposomal Drug Delivery Devices Market Forecast for DepoFoam Liposome Technology Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 38 Global Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ million, AGR%, CAGR%)
Table 39 Global Liposomal Drug Delivery Devices Market Forecast for Fungal Diseases Segment, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 40 Global Liposomal Drug Delivery Devices Market Forecast for Fungal Diseases Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 41 Global Liposomal Drug Delivery Devices Market Forecast for Fungal Diseases Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 42 Global Liposomal Drug Delivery Devices Market Forecast for Fungal Diseases Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 43 Global Liposomal Drug Delivery Devices Market Forecast for Fungal Diseases Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 44 FDA-approval drug products of injection delivery based on liposome technology (liposome, nanoparticle, nanosuspension, microemulsion, microsphere)
Table 45 Global Liposomal Drug Delivery Devices Market Forecast for Cancer Therapy Segment, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 46 Global Liposomal Drug Delivery Devices Market Forecast for Cancer Therapy Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 47 Global Liposomal Drug Delivery Devices Market Forecast for Cancer Therapy Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 48 Global Liposomal Drug Delivery Devices Market Forecast for Cancer Therapy Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 49 Global Liposomal Drug Delivery Devices Market Forecast for Cancer Therapy Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 50 Global Liposomal Drug Delivery Devices Market Forecast for Pain Management Segment, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 51 Global Liposomal Drug Delivery Devices Market Forecast for Pain Management Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 52 Global Liposomal Drug Delivery Devices Market Forecast for Pain Management Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 53 Global Liposomal Drug Delivery Devices Market Forecast for Pain Management Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 54 Global Liposomal Drug Delivery Devices Market Forecast for Pain Management Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 55 List of Pipeline Candidate Vaccine Formulations
Table 56 Global Liposomal Drug Delivery Devices Market Forecast for Viral Vaccines Segment, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 57 Global Liposomal Drug Delivery Devices Market Forecast for Viral Vaccines Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 58 Global Liposomal Drug Delivery Devices Market Forecast for Viral Vaccines Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 59 Global Liposomal Drug Delivery Devices Market Forecast for Viral Vaccines Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 60 Global Liposomal Drug Delivery Devices Market Forecast for Viral Vaccines Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 61 Encapsulation of Photosensitizers (PSs) into Liposomes in Cancer PDT
Table 62 Global Liposomal Drug Delivery Devices Market Forecast for Photodynamic Therapy Segment, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 63 Global Liposomal Drug Delivery Devices Market Forecast for Photodynamic Therapy Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 64 Global Liposomal Drug Delivery Devices Market Forecast for Photodynamic Therapy Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 65 Global Liposomal Drug Delivery Devices Market Forecast for Photodynamic Therapy Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 66 Global Liposomal Drug Delivery Devices Market Forecast for Photodynamic Therapy Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 67 Global Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ million, AGR%, CAGR%)
Table 68 Global Liposomal Drug Delivery Devices Market Forecast for Hospitals Segment, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 69 Global Liposomal Drug Delivery Devices Market Forecast for Hospitals Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 70 Global Liposomal Drug Delivery Devices Market Forecast for Hospitals Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 71 Global Liposomal Drug Delivery Devices Market Forecast for Hospitals Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 72 Global Liposomal Drug Delivery Devices Market Forecast for Hospitals Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 73 Global Liposomal Drug Delivery Devices Market Forecast for Diagnostic Centers Segment, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 74 Global Liposomal Drug Delivery Devices Market Forecast for Diagnostic Centers Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 75 Global Liposomal Drug Delivery Devices Market Forecast for Diagnostic Centers Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 76 Global Liposomal Drug Delivery Devices Market Forecast for Diagnostic Centers Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 77 Global Liposomal Drug Delivery Devices Market Forecast for Diagnostic Centers Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 78 Global Liposomal Drug Delivery Devices Market Forecast for Ambulatory Surgery Centers/Clinics Segment, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 79 Global Liposomal Drug Delivery Devices Market Forecast for Ambulatory Surgery Centers/Clinics Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 80 Global Liposomal Drug Delivery Devices Market Forecast for Ambulatory Surgery Centers/Clinics Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 81 Global Liposomal Drug Delivery Devices Market Forecast for Ambulatory Surgery Centers/Clinics Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 82 Global Liposomal Drug Delivery Devices Market Forecast for Ambulatory Surgery Centers/Clinics Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 83 Global Liposomal Drug Delivery Devices Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 84 Global Liposomal Drug Delivery Devices Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 85 Global Liposomal Drug Delivery Devices Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 86 Global Liposomal Drug Delivery Devices Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 87 Global Liposomal Drug Delivery Devices Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 88 North America Liposomal Drug Delivery Devices Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR%)
Table 89 North America Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR%)
Table 90 North America Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 91 North America Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 92 North America Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 93 North America Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 94 North America Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ million, AGR%, CAGR%)
Table 95 North America Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 96 North America Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 97 North America Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 98 North America Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 99 North America Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ million, AGR%, CAGR%)
Table 100 North America Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 101 North America Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 102 North America Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 103 North America Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 104 North America Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ million, AGR%, CAGR%)
Table 105 North America Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 106 North America Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 107 North America Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 108 North America Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 109 U.S. Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 110 U.S. Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 111 U.S. Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 112 U.S. Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 113 U.S. Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 114 Canada Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 115 Canada Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 116 Canada Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 117 Canada Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 118 Canada Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 119 Europe Liposomal Drug Delivery Devices Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR%)
Table 120 Europe Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR%)
Table 121 Europe Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 122 Europe Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 123 Europe Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 124 Europe Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 125 Europe Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ million, AGR%, CAGR%)
Table 126 Europe Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 127 Europe Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 128 Europe Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 129 Europe Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 130 Europe Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ million, AGR%, CAGR%)
Table 131 Europe Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 132 Europe Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 133 Europe Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 134 Europe Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 135 Europe Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ million, AGR%, CAGR%)
Table 136 Europe Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 137 Europe Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 138 Europe Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 139 Europe Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 140 Germany Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 141 Germany Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 142 Germany Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 143 Germany Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 144 Germany Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 145 UK Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 146 UK Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 147 UK Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 148 UK Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 149 UK Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 150 France Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 151 France Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 152 France Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 153 France Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 154 France Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 155 Italy Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 156 Italy Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 157 Italy Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 158 Italy Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 159 Italy Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 160 Spain Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 161 Spain Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 162 Spain Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 163 Spain Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 164 Spain Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 165 Russia Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 166 Russia Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 167 Russia Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 168 Russia Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 169 Russia Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 170 Rest of Europe Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 171 Rest of Europe Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 172 Rest of Europe Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 173 Rest of Europe Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 174 Rest of Europe Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 175 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR%)
Table 176 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR%)
Table 177 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 178 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 179 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 180 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 181 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ million, AGR%, CAGR%)
Table 182 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 183 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 184 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 185 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 186 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ million, AGR%, CAGR%)
Table 187 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 188 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 189 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 190 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 191 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ million, AGR%, CAGR%)
Table 192 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 193 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 194 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 195 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 196 Japan Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 197 Japan Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 198 Japan Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 199 Japan Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 200 Japan Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 201 China Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 202 China Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 203 China Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 204 China Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 205 China Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 206 India Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 207 India Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 208 India Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 209 India Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 210 India Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 211 Australia Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 212 Australia Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 213 Australia Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 214 Australia Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 215 Australia Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 216 South Korea Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 217 South Korea Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 218 South Korea Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 219 South Korea Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 220 South Korea Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 221 Rest of Asia Pacific Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 222 Rest of Asia Pacific Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 223 Rest of Asia Pacific Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 224 Rest of Asia Pacific Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 225 Rest of Asia Pacific Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 226 Latin America Liposomal Drug Delivery Devices Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR%)
Table 227 Latin America Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR%)
Table 228 Latin America Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 229 Latin America Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 230 Latin America Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 231 Latin America Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 232 Latin America Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ million, AGR%, CAGR%)
Table 233 Latin America Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 234 Latin America Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 235 Latin America Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 236 Latin America Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 237 Latin America Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ million, AGR%, CAGR%)
Table 238 Latin America Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 239 Latin America Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 240 Latin America Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 241 Latin America Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 242 Latin America Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ million, AGR%, CAGR%)
Table 243 Latin America Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 244 Latin America Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 245 Latin America Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 246 Latin America Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 247 Brazil Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 248 Brazil Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 249 Brazil Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 250 Brazil Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 251 Brazil Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 252 Mexico Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 253 Mexico Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 254 Mexico Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 255 Mexico Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 256 Mexico Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 257 Rest of Latin America Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 258 Rest of Latin America Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 259 Rest of Latin America Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 260 Rest of Latin America Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 261 Rest of Latin America Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 262 MEA Liposomal Drug Delivery Devices Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR%)
Table 263 MEA Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR%)
Table 264 MEA Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 265 MEA Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 266 MEA Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 267 MEA Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 268 MEA Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ million, AGR%, CAGR%)
Table 269 MEA Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 270 MEA Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 271 MEA Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 272 MEA Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 273 MEA Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ million, AGR%, CAGR%)
Table 274 MEA Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 275 MEA Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 276 MEA Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 277 MEA Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 278 MEA Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ million, AGR%, CAGR%)
Table 279 MEA Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 280 MEA Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 281 MEA Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 282 MEA Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 283 GCC Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 284 GCC Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 285 GCC Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 286 GCC Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 287 GCC Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 288 South Africa Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 289 South Africa Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 290 South Africa Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 291 South Africa Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 292 South Africa Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 293 Rest of MEA Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 294 Rest of MEA Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 295 Rest of MEA Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 296 Rest of MEA Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 297 Rest of MEA Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 298 Company Ranking, 2021
Table 299 Recent Developments: Liposomal Drug Delivery Devices Market
Table 300 Takeda Pharmaceutical Company Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 301 Takeda Pharmaceutical Company Limited: Product Benchmarking
Table 302 Novartis AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 303 Novartis AG: Product Benchmarking
Table 304 Novartis AG: Recent Developments
Table 305 Luye Pharma Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 306 Luye Pharma Group: Product Benchmarking
Table 307 Luye Pharma Group: Recent Developments
Table 308 Ipsen Pharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 309 Ipsen Pharma: Product Benchmarking
Table 310 Ipsen Pharma: Recent Developments
Table 311 Celsion, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 312 Celsion, Inc.: Product Benchmarking
Table 313 Celsion, Inc.: Recent Developments
Table 314 Galen Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 315 Galen Limited: Product Benchmarking
Table 316 Astellas Pharma, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 317 Astellas Pharma, Inc.: Product Benchmarking
Table 318 Astellas Pharma, Inc.: Recent Developments
Table 319 Acrotech Biopharma, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 320 Acrotech Biopharma, Inc.: Product Benchmarking
Table 321 Fudan-Zhangjiang: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 322 Fudan-Zhangjiang: Product Benchmarking
Table 323 Pacira: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 324 Pacira: Product Benchmarking
Table 325 Pacira: Recent Developments
Table 326 Creative Biolabs: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 327 Creative Biolabs: Product Benchmarking
Table 328 Precision NanoSystems Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 329 Precision NanoSystems Inc.: Product Benchmarking
Table 330 Encapsula NanoSciences LLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 331 Encapsula NanoSciences LLC.: Product Benchmarking
Table 332 Avanti Polar Lipids, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 333 Avanti Polar Lipids, Inc.: Product Benchmarking
Table 334 Viatris Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 335 Viatris Inc.: Product Benchmarking
Table 336 Merrimack Pharmaceuticals, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 337 Merrimack Pharmaceuticals, Inc.: Product Benchmarking

図の一覧
Figure 1 Global Liposomal Drug Delivery Devices Market: Market Segmentation
Figure 2 Global Liposomal Drug Delivery Devices Market Trends
Figure 3 Global Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ million, AGR %)
Figure 4 Global Liposomal Drug Delivery Devices Market Share Forecast by Type, 2022, 2027, 2032 (%)
Figure 5 Global Liposomal Drug Delivery Devices Market for Liposomal Doxorubicin Segment: Revenue Forecast 2022-2032 (US$ million, AGR%)
Figure 6 Global Liposomal Drug Delivery Devices Market for Liposomal Doxorubicin Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 7 Global Liposomal Drug Delivery Devices Market for Liposomal Doxorubicin Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 8 Global Liposomal Drug Delivery Devices Market for Liposomal Doxorubicin Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 9 Global Liposomal Drug Delivery Devices Market for Liposomal Doxorubicin Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 10 Global Liposomal Drug Delivery Devices Market for Liposomal Paclitaxel Segment: Revenue Forecast 2022-2032 (US$ million, AGR%)
Figure 11 Global Liposomal Drug Delivery Devices Market for Liposomal Paclitaxel Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 12 Global Liposomal Drug Delivery Devices Market for Liposomal Paclitaxel Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 13 Global Liposomal Drug Delivery Devices Market for Liposomal Paclitaxel Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 14 Global Liposomal Drug Delivery Devices Market for Liposomal Paclitaxel Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 15 Global Liposomal Drug Delivery Devices Market for Liposomal Amphotericin B Segment: Revenue Forecast 2022-2032 (US$ million, AGR%)
Figure 16 Global Liposomal Drug Delivery Devices Market for Liposomal Amphotericin B Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 17 Global Liposomal Drug Delivery Devices Market for Liposomal Amphotericin B Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 18 Global Liposomal Drug Delivery Devices Market for Liposomal Amphotericin B Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 19 Global Liposomal Drug Delivery Devices Market for Liposomal Amphotericin B Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 20 Global Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ million, AGR %)
Figure 21 Global Liposomal Drug Delivery Devices Market Share Forecast by Technology, 2022, 2027, 2032 (%)
Figure 22 Global Liposomal Drug Delivery Devices Market for Stealth Liposome Technology Segment: Revenue Forecast 2022-2032 (US$ million, AGR%)
Figure 23 Global Liposomal Drug Delivery Devices Market for Stealth Liposome Technology Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 24 Global Liposomal Drug Delivery Devices Market for Stealth Liposome Technology Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 25 Global Liposomal Drug Delivery Devices Market for Stealth Liposome Technology Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 26 Global Liposomal Drug Delivery Devices Market for Stealth Liposome Technology Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 27 Global Liposomal Drug Delivery Devices Market for Non-PEGylated Liposome Technology Segment: Revenue Forecast 2022-2032 (US$ million, AGR%)
Figure 28 Global Liposomal Drug Delivery Devices Market for Non-PEGylated Liposome Technology Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 29 Global Liposomal Drug Delivery Devices Market for Non-PEGylated Liposome Technology Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 30 Global Liposomal Drug Delivery Devices Market for Non-PEGylated Liposome Technology Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 31 Global Liposomal Drug Delivery Devices Market for Non-PEGylated Liposome Technology Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 32 Global Liposomal Drug Delivery Devices Market for DepoFoam Liposome Technology Segment: Revenue Forecast 2022-2032 (US$ million, AGR%)
Figure 33 Global Liposomal Drug Delivery Devices Market for DepoFoam Liposome Technology Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 34 Global Liposomal Drug Delivery Devices Market for DepoFoam Liposome Technology Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 35 Global Liposomal Drug Delivery Devices Market for DepoFoam Liposome Technology Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 36 Global Liposomal Drug Delivery Devices Market for DepoFoam Liposome Technology Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 37 Global Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ million, AGR %)
Figure 38 Global Liposomal Drug Delivery Devices Market Share Forecast by Application, 2022, 2027, 2032 (%)
Figure 39 Global Liposomal Drug Delivery Devices Market for Fungal Diseases Segment: Revenue Forecast 2022-2032 (US$ million, AGR%)
Figure 40 Global Liposomal Drug Delivery Devices Market for Fungal Diseases Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 41 Global Liposomal Drug Delivery Devices Market for Fungal Diseases Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 42 Global Liposomal Drug Delivery Devices Market for Fungal Diseases Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 43 Global Liposomal Drug Delivery Devices Market for Fungal Diseases Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 44 Global Liposomal Drug Delivery Devices Market for Cancer Therapy Segment: Revenue Forecast 2022-2032 (US$ million, AGR%)
Figure 45 Global Liposomal Drug Delivery Devices Market for Cancer Therapy Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 46 Global Liposomal Drug Delivery Devices Market for Cancer Therapy Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 47 Global Liposomal Drug Delivery Devices Market for Cancer Therapy Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 48 Global Liposomal Drug Delivery Devices Market for Cancer Therapy Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 49 Global Liposomal Drug Delivery Devices Market for Pain Management Segment: Revenue Forecast 2022-2032 (US$ million, AGR%)
Figure 50 Global Liposomal Drug Delivery Devices Market for Pain Management Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 51 Global Liposomal Drug Delivery Devices Market for Pain Management Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 52 Global Liposomal Drug Delivery Devices Market for Pain Management Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 53 Global Liposomal Drug Delivery Devices Market for Pain Management Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 54 Global Liposomal Drug Delivery Devices Market for Viral Vaccines Segment: Revenue Forecast 2022-2032 (US$ million, AGR%)
Figure 55 Global Liposomal Drug Delivery Devices Market for Viral Vaccines Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 56 Global Liposomal Drug Delivery Devices Market for Viral Vaccines Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 57 Global Liposomal Drug Delivery Devices Market for Viral Vaccines Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 58 Global Liposomal Drug Delivery Devices Market for Viral Vaccines Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 59 Global Liposomal Drug Delivery Devices Market for Photodynamic Therapy Segment: Revenue Forecast 2022-2032 (US$ million, AGR%)
Figure 60 Global Liposomal Drug Delivery Devices Market for Photodynamic Therapy Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 61 Global Liposomal Drug Delivery Devices Market for Photodynamic Therapy Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 62 Global Liposomal Drug Delivery Devices Market for Photodynamic Therapy Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 63 Global Liposomal Drug Delivery Devices Market for Photodynamic Therapy Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 64 Global Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ million, AGR %)
Figure 65 Global Liposomal Drug Delivery Devices Market Share Forecast by End-User, 2022, 2027, 2032 (%)
Figure 66 Global Liposomal Drug Delivery Devices Market for Hospitals Segment: Revenue Forecast 2022-2032 (US$ million, AGR%)
Figure 67 Global Liposomal Drug Delivery Devices Market for Hospitals Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 68 Global Liposomal Drug Delivery Devices Market for Hospitals Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 69 Global Liposomal Drug Delivery Devices Market for Hospitals Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 70 Global Liposomal Drug Delivery Devices Market for Hospitals Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 71 Global Liposomal Drug Delivery Devices Market for Diagnostic Centers Segment: Revenue Forecast 2022-2032 (US$ million, AGR%)
Figure 72 Global Liposomal Drug Delivery Devices Market for Diagnostic Centers Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 73 Global Liposomal Drug Delivery Devices Market for Diagnostic Centers Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 74 Global Liposomal Drug Delivery Devices Market for Diagnostic Centers Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 75 Global Liposomal Drug Delivery Devices Market for Diagnostic Centers Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 76 Global Liposomal Drug Delivery Devices Market for Ambulatory Surgery Centers/Clinics Segment: Revenue Forecast 2022-2032 (US$ million, AGR%)
Figure 77 Global Liposomal Drug Delivery Devices Market for Ambulatory Surgery Centers/Clinics Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 78 Global Liposomal Drug Delivery Devices Market for Ambulatory Surgery Centers/Clinics Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 79 Global Liposomal Drug Delivery Devices Market for Ambulatory Surgery Centers/Clinics Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 80 Global Liposomal Drug Delivery Devices Market for Ambulatory Surgery Centers/Clinics Segment, Revenue Forecast 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 81 Global Liposomal Drug Delivery Devices Market Forecast by Region 2022-2032 (US$ million)
Figure 82 Global Liposomal Drug Delivery Devices Market Share Forecast by Region 2022, 2027, 2032 (%)
Figure 83 Global Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 84 Global Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 85 Global Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 86 Global Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 87 North America Liposomal Drug Delivery Devices Market Forecast by Country 2022-2032 (US$ million)
Figure 88 North America Liposomal Drug Delivery Devices Market Share Forecast by Country 2022, 2027, 2032 (%)
Figure 89 North America Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ million, AGR%)
Figure 90 North America Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 91 North America Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 92 North America Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 93 North America Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 94 North America Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ million, AGR%)
Figure 95 North America Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 96 North America Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 97 North America Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 98 North America Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 99 North America Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ million, AGR%)
Figure 100 North America Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 101 North America Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 102 North America Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 103 North America Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 104 North America Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ million, AGR%)
Figure 105 North America Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 106 North America Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 107 North America Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 108 North America Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 109 U.S. Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 110 U.S. Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 111 U.S. Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 112 U.S. Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 113 U.S. Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 114 Canada Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 115 Canada Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 116 Canada Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 117 Canada Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 118 Canada Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 119 Europe Liposomal Drug Delivery Devices Market Forecast by Country 2022-2032 (US$ million)
Figure 120 Europe Liposomal Drug Delivery Devices Market Share Forecast by Country 2022, 2027, 2032 (%)
Figure 121 Europe Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ million, AGR%)
Figure 122 Europe Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 123 Europe Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 124 Europe Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 125 Europe Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 126 Europe Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ million, AGR%)
Figure 127 Europe Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 128 Europe Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 129 Europe Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 130 Europe Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 131 Europe Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ million, AGR%)
Figure 132 Europe Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 133 Europe Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 134 Europe Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 135 Europe Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 136 Europe Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ million, AGR%)
Figure 137 Europe Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 138 Europe Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 139 Europe Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 140 Europe Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 141 Germany Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 142 Germany Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 143 Germany Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 144 Germany Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 145 Germany Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 146 UK Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 147 UK Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 148 UK Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 149 UK Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 150 UK Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 151 France Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 152 France Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 153 France Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 154 France Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 155 France Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 156 Italy Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 157 Italy Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 158 Italy Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 159 Italy Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 160 Italy Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 161 Spain Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 162 Spain Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 163 Spain Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 164 Spain Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 165 Spain Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 166 Russia Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 167 Russia Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 168 Russia Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 169 Russia Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 170 Russia Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 171 Rest of Europe Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 172 Rest of Europe Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 173 Rest of Europe Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 174 Rest of Europe Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 175 Rest of Europe Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 176 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by Country 2022-2032 (US$ million)
Figure 177 Asia Pacific Liposomal Drug Delivery Devices Market Share Forecast by Country 2022, 2027, 2032 (%)
Figure 178 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ million, AGR%)
Figure 179 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 180 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 181 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 182 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 183 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ million, AGR%)
Figure 184 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 185 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 186 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 187 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 188 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ million, AGR%)
Figure 189 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 190 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 191 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 192 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 193 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ million, AGR%)
Figure 194 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 195 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 196 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 197 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 198 Japan Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 199 Japan Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 200 Japan Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 201 Japan Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 202 Japan Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 203 China Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 204 China Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 205 China Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 206 China Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 207 China Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 208 India Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 209 India Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 210 India Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 211 India Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 212 India Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 213 Australia Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 214 Australia Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 215 Australia Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 216 Australia Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 217 Australia Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 218 South Korea Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 219 South Korea Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 220 South Korea Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 221 South Korea Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 222 South Korea Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 223 Rest of Asia Pacific Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 224 Rest of Asia Pacific Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 225 Rest of Asia Pacific Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 226 Rest of Asia Pacific Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 227 Rest of Asia Pacific Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 228 Latin America Liposomal Drug Delivery Devices Market Forecast by Country 2022-2032 (US$ million)
Figure 229 Latin America Liposomal Drug Delivery Devices Market Share Forecast by Country 2022, 2027, 2032 (%)
Figure 230 Latin America Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ million, AGR%)
Figure 231 Latin America Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 232 Latin America Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 233 Latin America Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 234 Latin America Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 235 Latin America Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ million, AGR%)
Figure 236 Latin America Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 237 Latin America Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 238 Latin America Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 239 Latin America Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 240 Latin America Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ million, AGR%)
Figure 241 Latin America Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 242 Latin America Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 243 Latin America Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 244 Latin America Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 245 Latin America Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ million, AGR%)
Figure 246 Latin America Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 247 Latin America Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 248 Latin America Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 249 Latin America Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 250 Brazil Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 251 Brazil Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 252 Brazil Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 253 Brazil Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 254 Brazil Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 255 Mexico Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 256 Mexico Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 257 Mexico Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 258 Mexico Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 259 Mexico Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 260 Rest of Latin America Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 261 Rest of Latin America Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 262 Rest of Latin America Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 263 Rest of Latin America Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 264 Rest of Latin America Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 265 Middle East and Africa Liposomal Drug Delivery Devices Market Forecast by Country 2022-2032 (US$ million)
Figure 266 Middle East and Africa Liposomal Drug Delivery Devices Market Share Forecast by Country 2022, 2027, 2032 (%)
Figure 267 Middle East and Africa Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ million, AGR%)
Figure 268 Middle East and Africa Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 269 Middle East and Africa Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery2
Figure 270 Middle East and Africa Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 271 Middle East and Africa Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 272 Middle East and Africa Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ million, AGR%)
Figure 273 Middle East and Africa Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 274 Middle East and Africa Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 275 Middle East and Africa Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 276 Middle East and Africa Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 277 Middle East and Africa Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ million, AGR%)
Figure 278 Middle East and Africa Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 279 Middle East and Africa Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 280 Middle East and Africa Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 281 Middle East and Africa Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 282 Middle East and Africa Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ million, AGR%)
Figure 283 Middle East and Africa Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 284 Middle East and Africa Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 285 Middle East and Africa Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 286 Middle East and Africa Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 287 GCC Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 288 GCC Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 289 GCC Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 290 GCC Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 291 GCC Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 292 South Africa Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 293 South Africa Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 294 South Africa Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 295 South Africa Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 296 South Africa Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 297 Rest of Middle East and Africa Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 298 Rest of Middle East and Africa Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “V” Shaped Recovery
Figure 299 Rest of Middle East and Africa Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “U” Shaped Recovery
Figure 300 Rest of Middle East and Africa Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “W” Shaped Recovery
Figure 301 Rest of Middle East and Africa Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ million, AGR%): “L” Shaped Recovery
Figure 302 Takeda Pharmaceutical Company Limited: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 303 Takeda Pharmaceutical Company Limited: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 304 Takeda Pharmaceutical Company Limited: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 305 Novartis AG: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 306 Novartis AG: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 307 Novartis AG: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 308 Ipsen Pharma: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 309 Ipsen Pharma: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 310 Ipsen Pharma: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 311 Astellas Pharma, Inc.: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 312 Astellas Pharma, Inc.: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 313 Astellas Pharma, Inc.: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 314 Pacira: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 315 Pacira: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 316 Pacira: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 317 Viatris Inc.: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 318 Viatris Inc.: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 319 Viatris Inc.: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 320 Global Liposomal Drug Delivery Devices Market Share Forecast by Region 2022, 2027, 2032 (%)

 

ページTOPに戻る


 

Summary

この調査レポートは世界のリポソーム薬物送達デバイス市場を調査し、タイプ別、技術別、用途別、エンドユーザー別、地域別に2022年から2032年までの予測結果を掲載しています。また関連企業情報を提供しています。

主な掲載内容(目次より抜粋)

  1. レポート概要
  2. エグゼクティブサマリー
  3. 市場概要
  4. リポソーム薬物送達デバイスの市場:タイプ別
  5. リポソーム薬物送達デバイスの市場:技術別
  6. リポソーム薬物送達デバイスの市場:用途別
  7. リポソーム薬物送達デバイスの市場:エンドユーザー別
  8. リポソーム薬物送達デバイスの地域別・主要国別市場予測 2022年~2032年
  9. 北米のリポソーム薬物送達デバイス市場
  10. 欧州のリポソーム薬物送達デバイス市場
  11. アジア太平洋地域のリポソーム薬物送達デバイス市場
  12. ラテンアメリカのリポソーム薬物送達デバイス市場
  13. 中東・アフリカのリポソーム薬物送達デバイス市場
  14. 主要企業のプロフィール

Report Details

The Liposomal Drug Delivery Devices Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Liposomes have been Widely Explored as Drug Carriers for Improving Therapeutic Agent Delivery
Liposomes have been widely explored as drug carriers for improving therapeutic agent delivery to target body sites. As a result, a number of breakthroughs have been achieved, possibly making this technology helpful for the treatment of particular ailments. Liposomes increase medicine absorption while avoiding or minimising quick disintegration and adverse effects, prolonging the biological half-life and lowering toxicity. Liposomes are biocompatible, biodegradable, inert, and non-immunogenic lipids thus making them unique for as drug delivery carrier.

Due to their low immunogenicity, decreased toxicity, and capacity to carry larger cargo to target locations, liposomal formulations have witnessed a significant increase in scientific attention over the last decade, and have been demonstrated to be safer than viral vectors. Liposome-based drug delivery methods are used to administer anti-cancer, anti-fungal, and anti-inflammatory drugs, as well as therapeutic gene therapy.

Rising Awareness of Targeted Drug Delivery to Boost Market Growth
The rise in awareness of targeted drug delivery, an increase in cancer occurrences, and an increase in the functionalities of liposomes are likely to drive the growth of the liposomal medicines market in the forecast year. The increase in the price of liposomal drug delivery devices, on the other hand, is projected to challenge liposomal drug delivery devices industry expansion over the forecast period.

Furthermore, the growing adoption of liposomes in clinics due to their low toxicity and great efficacy will give further prospects for the liposomal pharmaceuticals market to develop in the future years. The rapid half-life cycle of liposomes, on the other hand, might hinder the market for liposomal medications in the near future.

North America liposomal drug delivery devices market is anticipated to lead the worldwide liposomal drug delivery market in 2022, and it is expected to continue to do so during the forecast period, owing to increased demand from the United States. Treatment of patients with ovarian cancer, AIDS-related Kaposi’s sarcoma, and fungal infections are among the major treatments driving regional market expansion. Furthermore, Asia Pacific liposomal drug delivery devices are expected to grow at the highest CAGR of 11.5% from 2022 to 2032. Demand for Asia-Pacific liposomal drug delivery devices market is expected to be fueled by China, India, and Japan. With rising concerns of stibanate resistance, India accounts for around half of worldwide visceral leishmaniasis (VL) infections, which is likely to enhance regional growth over the projection period.

What Questions Should You Ask before Buying a Market Research Report?
• How is the liposomal drug delivery devices market evolving?
• What is driving and restraining the liposomal drug delivery devices market?
• How will each liposomal drug delivery devices submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?
• How will the market shares for each liposomal drug delivery devices submarket develop from 2022 to 2032?
• What will be the main driver for the overall market from 2022 to 2032?
• Will leading liposomal drug delivery devices markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?
• Who are the leading players and what are their prospects over the forecast period?
• What are the Liposomal Drug Delivery Devices projects for these leading companies?
• How will the industry evolve during the period between 2022 and 2032? What are the implications of Liposomal Drug Delivery Devices projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the liposomal drug delivery devices market?
• Where is the liposomal drug delivery devices market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the liposomal drug delivery devices market today, and over the next 10 years:
• Our 535-page report provides 337 tables and 323 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the liposomal drug delivery devices market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

The report delivers exclusive COVID-19 variations and economic data specific to your market.

Forecasts to 2032 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Liposomal Drug Delivery Devices prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Type
• Liposomal Doxorubicin
• Liposomal Paclitaxel
• Liposomal Amphotericin B

Technology
• Stealth Liposome Technology
• NonPEGylated Liposome Technology
• DepoFoam Liposome Technology

Application
• Fungal Diseases
• Cancer Therapy
• Pain Management
• Viral Vaccines
• Photodynamic Therapy

End-user
• Hospitals
• Diagnostic Centers
• Ambulatory Surgery Centers/Clinics

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:

North America
• U.S.
• Canada

Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa
• GCC
• South Africa
• Rest of Middle East & Africa

The report also includes profiles and for some of the leading companies in the Liposomal Drug Delivery Devices Market, 2022 to 2032, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
• AbbVie Inc. (AbbVie)
• Bavarian Nordic A/S
• Catalent, Inc.
• Charles River Laboratories International, Inc.
• Emergent BioSolutions Inc.
• Eurofins Scientific SE
• FUJIFILM Holdings Corporation
• GlaxoSmithKline PLC
• Kemwell Biopharma
• Lonza Group AG (Lonza)
• Merck KGaA
• Pfizer Inc. (Pfizer)
• Richter-Helm BioLogics
• Samsung Biologics Co Ltd
• Sanofi SA
• Serum Institute of India
• Siegfried Holding AG
• Thermo Fisher Scientific Inc.
• Wacker Biotech B.V.
• WuXi Biologics Cayman Inc

Overall world revenue for Liposomal Drug Delivery Devices Market, 2022 to 2032 in terms of value the market will surpass US$4,091.1 million in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Liposomal Drug Delivery Devices Market, 2022 to 2032 report help you?
In summary, our 530+ page report provides you with the following knowledge:

• Revenue forecasts to 2032 for Liposomal Drug Delivery Devices Market, 2022 to 2032 Market, with forecasts for type, technology, application, and end-user, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2032 for four regional and 20 key national markets – See forecasts for the Liposomal Drug Delivery Devices Market, 2022 to 2032 market in North America, Europe, Asia-Pacific and LAMEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles for 20 of the major companies involved in the Liposomal Drug Delivery Devices Market, 2022 to 2032.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Liposomal Drug Delivery Devices Market, 2022 to 2032, market-leading companies. You will find data, trends and predictions.



ページTOPに戻る


Table of Contents

Table of Contents

1. Report Overview
1.1 Introduction to Liposomal Drug Delivery Devices Market
1.2 Liposomal Drug Delivery Devices Market Definition
1.3 Why You Should Read This Report
1.4 What This Report Delivers
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 COVID-19 Impact: Recovery Scenarios
1.7.2 Market Evaluation & Forecasting Methodology
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Dynamics
3.1 Drivers
3.1.1 Liposomal formulations assisting the delivery of nanomedicines
3.1.2 Growing application of Liposomal drug delivery for cancer treatment to drive market growth
3.1.3 Adoption of Nanomedicines to Boost Market Growth
3.1.4 Rising Product Approvals to Fuel Market Growth
3.1.5 Technological Advancements in Liposomal-based Medicinal Formulations to Spur Market Demand
3.2 Restraints
3.2.1 Lack of Standard Regulations to Stifle Market Growth
3.2.2 High Cost of Liposomal Drug Delivery Devices
3.2.3 Sterilization and Encapsulation Efficacy Issue to Restrain Market Growth
3.3 Opportunities
3.3.1 Emergence of COVID-19 Anticipated to Offer Lucrative Growth Opportunities
3.3.2 Nanomedicines Are Projected to Offer Lucrative Growth Prospects for Market Players
3.4 SWOT Analysis
3.4.1 Market Strengths
3.4.2 Market Weaknesses
3.4.3 Market Opportunities
3.4.4 Market Threats
3.5 Porter’s Five Forces Analysis
3.5.1 Competitive Rivalry (High)
3.5.2 Supplier Power (Low to Medium)
3.5.3 Buyer Power (Medium)
3.5.4 Threat from Substitutes (Low)
3.5.5 Threat of New Entrants (Low to Medium)
3.6 PEST Analysis
3.6.1 Political Factors Impacting Liposomal Drug Delivery Devices Market
3.6.2 Economic Factors Impacting Liposomal Drug Delivery Devices Market
3.6.3 Social Factors Impacting Liposomal Drug Delivery Devices Market
3.6.4 Technological Factors Impacting Liposomal Drug Delivery Devices Market

4 Liposomal Drug Delivery Devices Market by Type
4.1 Liposomal Doxorubicin Segment Market Forecast, 2022-2032
4.1.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.2 Liposomal Paclitaxel Segment Market Forecast, 2022-2032
4.2.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.3 Liposomal Amphotericin B Segment Market Forecast, 2022-2032
4.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)

5 Liposomal Drug Delivery Devices Market by Technology
5.1 Stealth Liposome Technology Segment Market Forecast, 2022-2032
5.1.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.2 Non-PEGylated Liposome Technology Segment Market Forecast, 2022-2032
5.2.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.3 DepoFoam Liposome Technology Segment Market Forecast, 2022-2032
5.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)

6 Liposomal Drug Delivery Devices Market by Application
6.1 Fungal Diseases Segment Market Forecast, 2022-2032
6.1.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.2 Cancer Therapy Segment Market Forecast, 2022-2032
6.2.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.3 Pain Management Segment Market Forecast, 2022-2032
6.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.4 Viral Vaccines Segment Market Forecast, 2022-2032
6.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.5 Photodynamic Therapy Segment Market Forecast, 2022-2032
6.5.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)

7 Liposomal Drug Delivery Devices Market by End-User
7.1 Hospitals Segment Market Forecast, 2022-2032
7.1.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
7.2 Diagnostic Centers (Radio Imaging) Segment Market Forecast, 2022-2032
7.2.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
7.3 Ambulatory Surgery Centers/Clinics Segment Market Forecast, 2022-2032
7.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)

8 Regional and Leading National Liposomal Drug Delivery Devices Market Forecasts 2022-2032
8.1 Introduction
8.2 Global Liposomal Drug Delivery Devices Market by Region Forecast 2022-2032
8.3 COVID-19 Impact Recovery Scenarios (V, U, W, L)

9 North America Liposomal Drug Delivery Devices Market
9.1 Introduction
9.2 North America Liposomal Drug Delivery Devices Market by Country, Forecast 2022-2032
9.3 North America Liposomal Drug Delivery Devices Market Forecast by Type
9.4 North America Liposomal Drug Delivery Devices Market Forecast by Technology
9.5 North America Liposomal Drug Delivery Devices Market Forecast by Application
9.6 North America Liposomal Drug Delivery Devices Market Forecast by End-User
9.7 U.S. Liposomal Drug Delivery Devices Market Forecast, 2022-2032
9.7.1 Growing Burden of Genetic Disorders to Boost U.S. Liposomal Drug Delivery Devices Market Growth
9.7.2 Rising Burden of Cancer to Fuel Regional Growth
9.7.3 U.S. Witnessing Significant Investment from Market Players
9.7.4 Pacira Announces FDA Approval of Supplemental New Drug Application For Exparel® (Bupivacaine Liposome Injectable Suspension) in Pediatric Patients
9.7.5 COVID-19 Impact Recovery Scenarios (V, U, W, L): U.S. Liposomal Drug Delivery Devices Market Forecast, 2022-2032
9.8 Canada Liposomal Drug Delivery Devices Market Forecast, 2022-2032
9.8.1 Ageing Population Across the Region to Boost Market Growth
9.8.2 Growing Cancer Burden to Offer Lucrative Growth Prospects for Canadian Market Players
9.8.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Canada Liposomal Drug Delivery Devices Market Forecast, 2022-2032

10 Europe Liposomal Drug Delivery Devices Market
10.1 Introduction
10.2 Europe Liposomal Drug Delivery Devices Market by Country, Forecast 2022-2032
10.3 Europe Liposomal Drug Delivery Devices Market Forecast by Type
10.4 Europe Liposomal Drug Delivery Devices Market Forecast by Technology
10.5 Europe Liposomal Drug Delivery Devices Market Forecast by Application
10.6 Europe Liposomal Drug Delivery Devices Market Forecast by End-User
10.7 Germany Liposomal Drug Delivery Devices Market Forecast, 2022-2032
10.7.1 Germany is Ideal Location for the Development & Manufacturing of High Quality Research Intensive Products
10.7.2 Growing Demand for Liposomal Based Therapy to Boost Market Growth
10.7.3 Evonik Has Launched Next-Generation LIPEX® Extruder for Fast and Effective Liposomal Drug Manufacturing
10.7.4 COVID-19 Impact Recovery Scenarios (V, U, W, L): Germany Liposomal Drug Delivery Devices Market Forecast, 2022-2032
10.8 UK Liposomal Drug Delivery Devices Market Forecast, 2022-2032
10.8.1 T&T Scientific Has Introduced Low-cost Fully-assemble Liposome Extrusion Device
10.8.2 Acquisition of Avanti Polar Lipids, Inc. by Croda International PLC
10.8.3 Rising Cancer Burden to Fuel Market Growth
10.8.4 Invasive Fungal Diseases to Fuel Regional Market Growth
10.8.5 COVID-19 Impact Recovery Scenarios (V, U, W, L): UK Liposomal Drug Delivery Devices Market Forecast, 2022-2032
10.9 France Liposomal Drug Delivery Devices Market Forecast, 2022-2032
10.9.1 Growing Need to Strengthen French Biotech Sector to Fuel Regional Liposomes Drug Delivery Devices Market Growth
10.9.2 Rising Incidence of Chronic Diseases to Boost Regional Growth
10.9.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): France Liposomal Drug Delivery Devices Market Forecast, 2022-2032
10.10 Italy Liposomal Drug Delivery Devices Market Forecast, 2022-2032
10.10.1 Italy is a Major Pharmaceutical Manufacturer across Europe
10.10.2 Growing Research Activities to Boost Regional Growth
10.10.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Italy Liposomal Drug Delivery Devices Market Forecast, 2022-2032
10.11 Spain Liposomal Drug Delivery Devices Market Forecast, 2022-2032
10.11.1 Growing Burden of Cancer to Fuel Market Growth
10.11.2 GP Pharma’s Liposomes for Injection
10.11.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Spain Liposomal Drug Delivery Devices Market Forecast, 2022-2032
10.12 Russia Liposomal Drug Delivery Devices Market Forecast, 2022-2032
10.12.1 Government Initiatives to Offer Lucrative Growth Prospects for Russian Liposomal Drug Delivery Devices Market Players
10.12.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Russia Liposomal Drug Delivery Devices Market Forecast, 2022-2032
10.13 Rest of Europe Liposomal Drug Delivery Devices Market Forecast, 2022-2032
10.13.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Europe Liposomal Drug Delivery Devices Market Forecast, 2022-2032

11 Asia Pacific Liposomal Drug Delivery Devices Market
11.1 Introduction
11.2 Asia Pacific Liposomal Drug Delivery Devices Market by Country, Forecast 2022-2032
11.3 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by Type
11.4 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by Technology
11.5 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by Application
11.6 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by End-User
11.7 Japan Liposomal Drug Delivery Devices Market Forecast, 2022-2032
11.7.1 Japanese Pharmaceutical Sector is Undergoing Significant Changes
11.7.2 Fujifilm Begins Contract Services of Process Development and Manufacturing of Liposomes Formulation
11.7.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Japan Liposomal Drug Delivery Devices Market Forecast, 2022-2032
11.8 China Liposomal Drug Delivery Devices Market Forecast, 2022-2032
11.8.1 Healthcare Reforms by Chinese Government to Offer Lucrative Growth Opportunities
11.8.2 Luye Pharma Group Announced Approval of Dulaglutide Injection (BA5101)
11.8.3 TLC Biosciences Announces Results of TLC599 Phase 2
11.8.4 COVID-19 Impact Recovery Scenarios (V, U, W, L): China Liposomal Drug Delivery Devices Market Forecast, 2022-2032
11.9 India Liposomal Drug Delivery Devices Market Forecast, 2022-2032
11.9.1 Pharmaceutical businesses across India have been increasing their capabilities
11.9.2 Amphotericin B Liposomal Injection Approval by DGCI (Drug Controller General of India)
11.9.3 Ageing Population to Boost Market Growth
11.9.4 COVID-19 Impact Recovery Scenarios (V, U, W, L): India Liposomal Drug Delivery Devices Market Forecast, 2022-2032
11.10 Australia Liposomal Drug Delivery Devices Market Forecast, 2022-2032
11.10.1 UNSW Team Taps Light-Activated Liposomes for Safer CRISPR Delivery
11.10.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Australia Liposomal Drug Delivery Devices Market Forecast, 2022-2032
11.11 South Korea Liposomal Drug Delivery Devices Market Forecast, 2022-2032
11.11.1 South Korean Researchers Ready to Commercialize Technology for Mass Production of Liposomes
11.11.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): South Korea Liposomal Drug Delivery Devices Market Forecast, 2022-2032
11.12 Rest of Asia Pacific Liposomal Drug Delivery Devices Market Forecast, 2022-2032
11.12.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Asia Pacific Liposomal Drug Delivery Devices Market Forecast, 2022-2032

12 Latin America Liposomal Drug Delivery Devices Market
12.1 Introduction
12.2 Latin America Liposomal Drug Delivery Devices Market by Country, Forecast 2022-2032
12.3 Latin America Liposomal Drug Delivery Devices Market Forecast by Type
12.4 Latin America Liposomal Drug Delivery Devices Market Forecast by Technology
12.5 Latin America Liposomal Drug Delivery Devices Market Forecast by Application
12.6 Latin America Liposomal Drug Delivery Devices Market Forecast by End-User
12.7 Brazil Liposomal Drug Delivery Devices Market Forecast, 2022-2032
12.7.1 Brazil Currently Dominates the Latin American Liposomal Drug Delivery Devices Market
12.7.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Brazil Liposomal Drug Delivery Devices Market Forecast, 2022-2032
12.8 Mexico Liposomal Drug Delivery Devices Market Forecast, 2022-2032
12.8.1 Implementations of Health Reforms to Offer Lucrative Growth Opportunities for Market Players
12.8.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Mexico Liposomal Drug Delivery Devices Market Forecast, 2022-2032
12.9 Rest of Latin America Liposomal Drug Delivery Devices Market Forecast, 2022-2032
12.9.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Latin America Liposomal Drug Delivery Devices Market Forecast, 2022-2032

13 Middle East and Africa Liposomal Drug Delivery Devices Market
13.1 Introduction
13.2 Middle East and Africa Liposomal Drug Delivery Devices Market by Country, Forecast 2022-2032
13.3 Middle East and Africa Liposomal Drug Delivery Devices Market Forecast by Type
13.4 Middle East and Africa Liposomal Drug Delivery Devices Market Forecast by Technology
13.5 Middle East and Africa Liposomal Drug Delivery Devices Market Forecast by Application
13.6 Middle East and Africa Liposomal Drug Delivery Devices Market Forecast by End-User
13.7 GCC Liposomal Drug Delivery Devices Market Forecast, 2022-2032
13.7.1 Growing Healthcare Investments to Boost Regional Growth Through 2032
13.7.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): GCC Liposomal Drug Delivery Devices Market Forecast, 2022-2032
13.8 South Africa Liposomal Drug Delivery Devices Market Forecast, 2022-2032
13.8.1 Growing Burden of Infectious Diseases to Fuel Market Growth over the Next Decade
13.8.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): South Africa Liposomal Drug Delivery Devices Market Forecast, 2022-2032
13.9 Rest of Middle East and Africa Liposomal Drug Delivery Devices Market Forecast, 2022-2032
13.9.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Middle East and Africa Liposomal Drug Delivery Devices Market Forecast, 2022-2032

14 Company Profiles
14.1 Company Ranking, 2021
14.2 Recent Developments
14.3 Takeda Pharmaceutical Company Limited
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.4 Product Benchmarking
14.4 Novartis AG
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Financial Analysis
14.4.4 Product Benchmarking
14.4.5 Recent Developments
14.5 Luye Pharma Group
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Product Benchmarking
14.5.4 Recent Developments
14.6 Ipsen Pharma
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis
14.6.4 Product Benchmarking
14.6.5 Recent Developments
14.7 Celsion, Inc.
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Product Benchmarking
14.7.4 Recent Developments
14.8 Galen Limited
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Product Benchmarking
14.9 Astellas Pharma, Inc.
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Financial Analysis
14.9.4 Product Benchmarking
14.9.5 Recent Developments
14.10 Acrotech Biopharma, Inc.
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Product Benchmarking
14.11 Fudan-Zhangjiang
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Product Benchmarking
14.12 Pacira
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Financial Analysis
14.12.4 Product Benchmarking
14.12.5 Recent Developments
14.13 Creative Biolabs
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Product Benchmarking
14.14 Precision NanoSystems Inc.
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Product Benchmarking
14.15 Encapsula NanoSciences LLC
14.15.1 Company Snapshot
14.15.2 Company Overview
14.15.3 Product Benchmarking
14.16 Avanti Polar Lipids, Inc.
14.16.1 Company Snapshot
14.16.2 Company Overview
14.16.3 Product Benchmarking
14.17 Viatris Inc.
14.17.1 Company Snapshot
14.17.2 Company Overview
14.17.3 Financial Analysis
14.17.4 Product Benchmarking
14.18 Merrimack Pharmaceuticals, Inc.
14.18.1 Company Snapshot
14.18.2 Company Overview
14.18.3 Product Benchmarking

15 Conclusion and Recommendations
15.1 Concluding Remarks
15.2 Recommendations for Market Players

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同じKEY WORD(ambulatory surgery)の最新刊レポート


よくあるご質問


Visiongain社はどのような調査会社ですか?


英国の調査会社ヴィジョンゲイン社(Visiongain)は、通信とエネルギーのほか、自動車や化学・医薬品、金属など、広範な市場を対象に調査を行っています。自動車市場については、市場全般に関する調査のほ... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/07/12 10:27

160.11 円

174.44 円

209.47 円

ページTOPに戻る